Published: Guidance, quality standards and advice
Showing 1 to 6 of 6
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Endoscopic sleeve gastroplasty for obesity | IPG783 | ||
| Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations | TA952 | ||
| Tuberculosis | NG33 | ||
| Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over | TA949 | ||
| Nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over | TA950 | ||
| Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer | TA951 |